Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00665795
Other study ID # 1152/05
Secondary ID
Status Completed
Phase N/A
First received April 22, 2008
Last updated November 17, 2013
Start date July 2005
Est. completion date November 2013

Study information

Verified date November 2013
Source University of Sao Paulo
Contact n/a
Is FDA regulated No
Health authority Brazil: National Committee of Ethics in Research
Study type Observational

Clinical Trial Summary

The purpose of this protocol is to study orbital structures in Graves´ Disease using multidetector computed tomography and color doppler imaging.

Some changes in orbital structures detected by imaging exams could predict severity of the ocular Graves´disease. Thus the study could be useful in improve medical management of patients with Graves´ Disease.


Description:

Morphometric analysis of orbital structures in Graves´ Orbitopathy using multidetector computed tomography scan and color doppler imaging:

Patients with Graves´ orbitopathy are evaluated by a complete ophthalmic examination.A prospective study with Multidetector CT scan and Color Doppler of these patients are made to develop parameters capable to predict Dysthyroid Optic Neuropathy (DON).


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date November 2013
Est. primary completion date November 2013
Accepts healthy volunteers No
Gender Both
Age group 20 Years and older
Eligibility Inclusion Criteria:

- Graves´Orbitopathy diagnosed based on previously reported criteria

- Age above 20 years

- Good cooperation for performing Visual Field test

- Spherical refraction within ± 5 D and cylinder correction within ± 3 D

Exclusion Criteria:

- Graves´Orbitopathy not diagnosed

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Brazil General Hospital - University of Sao Paulo - School of Medicine São Paulo

Sponsors (1)

Lead Sponsor Collaborator
University of Sao Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary screening indexes for dysthyroid optic neuropathy indexes above 60% of orbital apex crowding were high suspected for DON No
See also
  Status Clinical Trial Phase
Completed NCT03667157 - Liver Function After Intravenous Methylprednisolone Administration Phase 4